Literature DB >> 33758281

Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study.

Ha Il Kim1, Seo Young Park2, Hyun Phil Shin3,4.   

Abstract

The recent incidence and management patterns of alcohol-related liver disease (ARLD) are not well defined in Korea. We sought to evaluate the epidemiology of ARLD with regard to disease severity and alcohol cessation management after diagnosis. We performed an observational cohort study of standardized Common Data Model data from the Health Insurance Review and Assessment-National Patient Samples database between 2012 and 2016. The incidence and demographic properties of ARLD were extracted and divided into non-cirrhotic alcoholic liver disease (ALD) and alcoholic liver cirrhosis (ALC). ALC was compared with non-alcoholic cirrhosis by severity at diagnosis. The management patterns were captured by the initiation of pharmaco- and behavioral therapy for alcohol cessation. We analyzed data from 72,556 ALD to 7295 ALC patients. The ALD incidence was stable from 990 to 1025 per 100,000 people. In ALD, the proportion of patients who were ≥ 65 years old, the proportion of female patients, and the comorbidity index increased significantly during the study period (all P values < 0.001). ALC accounted for > 20% of all cirrhosis, with decompensation occurring twice as often as in non-alcoholic cirrhosis. The initiation of alcoholism management was stationary in ARLD, remaining at < 10% for both pharmacotherapy and behavioral therapy, regardless of severity or the site of diagnosis. The incidence of ARLD did not decrease during the study period. Moreover, an increasing trend in the proportion of people vulnerable to drinking was observed. Unfortunately, management for the cessation of alcohol use remains very low. The best way to manage ARLD should be evaluated in further study.

Entities:  

Year:  2021        PMID: 33758281     DOI: 10.1038/s41598-021-86197-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  36 in total

1.  Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide.

Authors:  Eva Stein; Monica Cruz-Lemini; Jose Altamirano; Nambi Ndugga; David Couper; Juan G Abraldes; Ramon Bataller
Journal:  J Hepatol       Date:  2016-07-05       Impact factor: 25.083

Review 2.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

Review 3.  Treatment of alcohol use disorders in patients with alcoholic liver disease.

Authors:  Giovanni Addolorato; Antonio Mirijello; Pablo Barrio; Antoni Gual
Journal:  J Hepatol       Date:  2016-05-04       Impact factor: 25.083

Review 4.  Treating alcohol-related liver disease from a public health perspective.

Authors:  Theresa Hydes; William Gilmore; Nick Sheron; Ian Gilmore
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

5.  Alcohol-related liver disease: Time for action.

Authors:  Ramon Bataller; Gavin E Arteel; Christophe Moreno; Vijay Shah
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 6.  The current situation of treatment systems for alcoholism in Korea.

Authors:  Jee Wook Kim; Boung Chul Lee; Tae-Cheon Kang; Ihn-Geun Choi
Journal:  J Korean Med Sci       Date:  2013-01-29       Impact factor: 2.153

7.  Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.

Authors:  Joshua D Lee; Edward V Nunes; Patricia Novo; Ken Bachrach; Genie L Bailey; Snehal Bhatt; Sarah Farkas; Marc Fishman; Phoebe Gauthier; Candace C Hodgkins; Jacquie King; Robert Lindblad; David Liu; Abigail G Matthews; Jeanine May; K Michelle Peavy; Stephen Ross; Dagmar Salazar; Paul Schkolnik; Dikla Shmueli-Blumberg; Don Stablein; Geetha Subramaniam; John Rotrosen
Journal:  Lancet       Date:  2017-11-14       Impact factor: 79.321

Review 8.  Global burden of alcoholic liver diseases.

Authors:  Jürgen Rehm; Andriy V Samokhvalov; Kevin D Shield
Journal:  J Hepatol       Date:  2013-03-16       Impact factor: 25.083

Review 9.  Epidemiology of alcoholic liver disease in Korea.

Authors:  Jae Young Jang; Dong Joon Kim
Journal:  Clin Mol Hepatol       Date:  2018-03-16

10.  Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017.

Authors:  Seung Ha Park; Lindsay D Plank; Ki Tae Suk; Yong Eun Park; Jin Lee; Joon Hyuk Choi; Nae Yun Heo; Jongha Park; Tae Oh Kim; Young Soo Moon; Hyun Kuk Kim; Hang Jea Jang; Ha Young Park; Dong Joon Kim
Journal:  Clin Mol Hepatol       Date:  2019-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.